Stay updated on Taletrectinib ROS1+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.

Latest updates to the Taletrectinib ROS1+ NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe site’s interface revision label updates from v3.5.2 to v3.5.3, reflecting a ClinicalTrials.gov platform/version release. No study-related information or record content changes are indicated by this change.SummaryDifference0.1%

- Check21 days agoChange DetectedAdded Revision: v3.5.2 to the history and removed Revision: v3.5.0.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedRevision history now includes a new entry for v3.5.0 and removes the previous v3.4.3 entry.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry v3.4.3 was added to the Record History, and the previous entry v3.4.2 was removed.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision v3.4.2 was added to the history, and a government funding notice along with the previous revision v3.4.1 were removed. These changes pertain to site-wide maintenance and do not alter the study data or record content.SummaryDifference0.7%

- Check92 days agoChange DetectedNotice about government funding lapse and NIH Clinical Center status was added. The revision label was updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.7%

Stay in the know with updates to Taletrectinib ROS1+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.